Embecta (EMBC) P/E (2022 - 2026)
Embecta (EMBC) P/E from Apr 1, 2022 to Jul 21, 2026. The TTM Embecta (EMBC) P/E is 1.77. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Embecta (EMBC)
| Year | P/E | Change |
|---|---|---|
| 2026 | 1.77 | -64.60% |
| 2025 | 5.00 | -67.13% |
| 2024 | 15.20 | -1.25% |
| 2023 | 15.40 | +136.70% |
| 2022 | 6.50 | N/A |
Comparison Embecta (EMBC) P/E with competitors
Embecta (EMBC) P/E is 1.77.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -87.34% |
| SOLV | Solventum Corp | 9.49 | +436.59% |
| ZJYL | Jin Medical International Ltd | 12.75 | +620.59% |
| PDEX | Pro-Dex Inc (co) | 15.22 | +760.37% |
| RMD | Resmed Inc | 19.04 | +976.64% |
| UTMD | Utah Medical Products Inc | 20.76 | +1073.58% |
| ATR | Aptargroup Inc | 21.65 | +1123.75% |
| ALGN | Align Technology Inc | 30.29 | +1612.43% |
| HOLX | Hologic Inc | 30.86 | +1644.79% |
| MMSI | Merit Medical Systems Inc | 31.15 | +1660.74% |
| STVN | Stevanato Group Spa | 31.25 | +1666.84% |
| LMAT | Lemaitre Vascular Inc | 36.34 | +1954.38% |
| ALC | Alcon Inc | 41.51 | +2246.90% |
| ISRG | Intuitive Surgical Inc | 46.43 | +2524.61% |
| BDX | Becton Dickinson & Company | 46.93 | +2553.13% |
| WST | West Pharmaceutical Services Inc | 47.41 | +2580.02% |
| NEPH | Nephros Inc | 50.00 | +2726.37% |
| COO | Cooper Companies Inc | 58.98 | +3234.14% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | +3416.22% |
| NVST | Envista Holdings Corp | 64.66 | +3555.55% |
| BAX | Baxter International Inc | 72.66 | +4007.37% |
| ICUI | ICU Medical Inc | 84.82 | +4695.03% |
| RGEN | Repligen Corp | 162.20 | +9069.24% |
| WRBY | Warby Parker Inc - Class A | 318.30 | +17893.93% |